GO:0019915 lipid storage: Cellular Process, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0019915 lipid storage is the biological process of accumulating and maintaining lipids in cells or tissues, often for later mobilization.
• Lipid droplets are the primary organelles responsible for storing neutral lipids, and their dynamics are regulated by numerous proteins.
• Dysregulation of lipid storage contributes to metabolic diseases, lysosomal acid lipase deficiency, and lipid storage myopathies.
• Key genes include PLIN1, DGAT1, ATGL, HSL, and LIPA, which control lipid droplet formation, lipolysis, and lipid turnover.
• Model organisms such as yeast, reptiles, and mammals provide insights into conserved and specialized lipid storage mechanisms.
• CRISPR-based knockout, knock-in, and overexpression models enable precise dissection of lipid storage pathways in vitro and in vivo.
Description
Lipid storage (GO:0019915) is a fundamental biological process defined as the accumulation and maintenance of lipids, which are compounds soluble in organic solvents but insoluble or sparingly soluble in aqueous solvents. This process allows cells and tissues to store energy reserves, membrane components, and signaling molecules, which can be mobilized during periods of nutrient scarcity or developmental transitions. Lipid storage is conserved across evolution, from yeast to reptiles to humans, and is critical for normal physiology and survival. Researchers study lipid storage to understand metabolic disorders, obesity, lipodystrophies, and lysosomal storage diseases, as well as to develop therapeutic strategies targeting lipid metabolism. The process is dynamically regulated by lipid droplet-associated proteins, lipases, and signaling pathways that respond to nutritional and hormonal cues.
lipid storage At A Glance
| GO ID | GO:0019915 |
|---|---|
| GO term | lipid storage |
| Ontology | biological_process |
| Synonym | lipid retention, lipid sequestering, lipid sequestration, retention of lipids, sequestering of lipids, sequestration of lipid, sequestration of lipids, storage of lipids |
| Major function | Accumulation and maintenance of lipids in cells or tissues for energy storage, membrane synthesis, and signaling |
| Related cellular component | Lipid droplet |
| Key enzymes | DGAT1, DGAT2, ATGL, HSL, LIPA |
| Associated diseases | Lysosomal acid lipase deficiency, neutral lipid storage disease, obesity |
| Model organisms | Saccharomyces cerevisiae, Schizosaccharomyces pombe, reptiles, mammals |
What Is GO:0019915?
GO:0019915 lipid storage refers to the biological process by which cells or tissues accumulate and maintain lipids, including neutral lipids such as triglycerides and sterol esters, within specialized organelles called lipid droplets. This definition encompasses the retention, sequestration, and storage of lipids, which can be accumulated during early developmental stages for later mobilization and utilization. The process is essential for energy homeostasis, membrane biogenesis, and lipid signaling, and it is tightly regulated by enzymes and structural proteins that control lipid droplet formation, growth, and degradation.
Why Is lipid storage Important in Cell Biology?
Lipid storage is essential for energy homeostasis, and its dysregulation is linked to a wide range of human diseases, including obesity, type 2 diabetes, atherosclerosis, and lysosomal acid lipase deficiency. Understanding the molecular mechanisms of lipid storage provides insights into normal physiology and disease pathogenesis, and it informs the development of therapies targeting lipid metabolism.
• Maintains energy balance by storing excess fatty acids as triglycerides in lipid droplets.
• Provides substrates for membrane synthesis and lipid signaling molecules.
• Protects cells from lipotoxicity by sequestering excess lipids.
• Dysregulation leads to metabolic disorders such as obesity and lipodystrophy.
• Mutations in LIPA cause lysosomal acid lipase deficiency, a severe lipid storage disease.
• Lipid storage in platelets affects transfusion medicine and storage quality.
• Reptiles use lipid storage for seasonal energy reserves and reproduction.
• Yeast models reveal conserved mechanisms of lipid droplet biology.
• Lipid droplet dynamics influence cancer cell survival and drug resistance.
• CRISPR screens can identify novel regulators of lipid storage.
What Happens During lipid storage?
Lipid Droplet Biogenesis
In simple terms: Cells create specialized fat storage droplets when excess lipids are present.
Lipid droplets originate from the endoplasmic reticulum, where neutral lipids such as triglycerides and sterol esters are synthesized by enzymes including DGAT1 and DGAT2. These lipids accumulate between the leaflets of the ER membrane, forming a lens that eventually buds off as a nascent lipid droplet. Proteins such as perilipins (PLIN1-5) then coat the droplet surface, stabilizing it and regulating access by lipases.
Lipid Droplet Growth and Maintenance
In simple terms: Droplets can grow larger and are maintained by a balance of lipid synthesis and breakdown.
Lipid droplets can grow by fusion or by local synthesis of triglycerides on their surface, mediated by enzymes like DGAT2. Maintenance of lipid stores requires a balance between lipogenesis and lipolysis; perilipins protect droplets from premature lipolysis, while lipases such as ATGL and HSL are recruited under lipolytic conditions. The size and number of lipid droplets are dynamically regulated in response to cellular stress and nutrient availability.
Lipolysis and Mobilization
In simple terms: When energy is needed, stored lipids are broken down and released.
Lipolysis is initiated by adipose triglyceride lipase (ATGL), which removes the first fatty acid from triglycerides, followed by hormone-sensitive lipase (HSL) and monoglyceride lipase (MGL). This process is regulated by signaling pathways such as cAMP-PKA, which phosphorylates perilipins and lipases to promote lipid droplet access. In lysosomes, acid lipase (LIPA) hydrolyzes cholesteryl esters and triglycerides delivered via autophagy or endocytosis.
Lipid Storage in Specialized Tissues
In simple terms: Different organisms and tissues have unique ways of storing lipids.
In reptiles, lipid storage occurs in fat bodies and liver, and is mobilized during hibernation and reproduction. In yeast, lipid droplets store sterol esters and triglycerides, and their metabolism is regulated by the cell cycle and nutrient status. In mammals, white adipose tissue is the primary site of lipid storage, while brown adipose tissue specializes in lipid oxidation for thermogenesis.
Lipid Storage and Cellular Stress
In simple terms: Storing lipids helps cells cope with stress and avoid damage from excess fats.
Lipid droplets buffer cellular stress by sequestering toxic lipids and providing a reservoir for membrane repair and energy production. During stress, lipid droplet abundance increases, and their interactions with other organelles such as mitochondria and lysosomes are enhanced. This adaptive response is crucial for cell survival under conditions like hypoxia, oxidative stress, and nutrient deprivation.
Key Genes Involved in GO:0019915 lipid storage
The following genes and proteins are central to lipid storage, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PLIN1 | Perilipin 1 coats lipid droplets and regulates lipolysis | Mutations cause familial partial lipodystrophy; target for obesity research |
| PLIN2 | Perilipin 2 stabilizes lipid droplets and prevents lipotoxicity | Highly expressed in liver and muscle; marker of steatosis |
| DGAT1 | Diacylglycerol O-acyltransferase 1 synthesizes triglycerides | Knockout mice are resistant to diet-induced obesity; drug target |
| DGAT2 | Diacylglycerol O-acyltransferase 2 synthesizes triglycerides | Essential for lipid droplet growth; involved in hepatic steatosis |
| ATGL (PNPLA2) | Adipose triglyceride lipase initiates lipolysis | Mutations cause neutral lipid storage disease with myopathy |
| HSL (LIPE) | Hormone-sensitive lipase hydrolyzes diacylglycerols | Regulates lipolysis in adipose tissue; linked to insulin resistance |
| LIPA | Lysosomal acid lipase hydrolyzes cholesteryl esters and triglycerides | Deficiency causes Wolman disease and cholesteryl ester storage disease |
| CIDEC | Cell death-inducing DFFA-like effector C promotes lipid droplet fusion | Mutations cause partial lipodystrophy; regulates energy storage |
| FSP27 (CIDEC) | Promotes lipid droplet enlargement and storage | Knockout mice have increased lipolysis and reduced fat mass |
| SREBP1 | Sterol regulatory element-binding protein 1 activates lipogenic genes | Master regulator of lipid synthesis and storage |
| PPARG | Peroxisome proliferator-activated receptor gamma promotes adipogenesis | Target of thiazolidinediones for diabetes; regulates lipid storage |
| CIDEa | Cell death-inducing DFFA-like effector A regulates lipid droplet size | Involved in brown adipose tissue lipid storage |
| G0S2 | G0/G1 switch 2 inhibits ATGL activity | Regulates lipolysis and lipid storage in adipose tissue |
| ABHD5 | Alpha/beta hydrolase domain-containing 5 activates ATGL | Mutations cause Chanarin-Dorfman syndrome |
| PLIN5 | Perilipin 5 links lipid droplets to mitochondria | Promotes lipid storage and oxidation in oxidative tissues |
| MGL (MGLL) | Monoglyceride lipase hydrolyzes monoglycerides | Completes lipolysis; involved in endocannabinoid signaling |
| ACSL1 | Acyl-CoA synthetase long-chain family member 1 activates fatty acids | Required for triglyceride synthesis and lipid storage |
| GPAT1 | Glycerol-3-phosphate acyltransferase 1 catalyzes the first step of glycerolipid synthesis | Regulates hepatic lipid storage and insulin sensitivity |
How Is lipid storage Regulated?
Lipid storage is regulated by a complex network of signaling pathways and transcription factors. The mTOR pathway promotes lipid synthesis and storage by activating SREBP1 and PPARG, while AMPK inhibits lipogenesis and stimulates lipolysis under energy stress. Hormonal signals such as insulin and glucagon reciprocally control lipogenic and lipolytic enzymes. Additionally, perilipins and lipases are regulated by phosphorylation, and lipid droplet dynamics are influenced by cellular stress and nutrient availability. In yeast, lipid storage is regulated by the cell cycle and nutrient-sensing pathways.
lipid storage and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| LIPA | Lysosomal acid lipase deficiency (Wolman disease, CESD) | LIPA knockout mice; patient-derived iPSCs; knock-in of patient mutations |
| PNPLA2 (ATGL) | Neutral lipid storage disease with myopathy | ATGL knockout mice; muscle-specific knockout; point mutation knock-in |
| ABHD5 | Chanarin-Dorfman syndrome | ABHD5 knockout mice; patient fibroblasts; CRISPR correction |
| PLIN1 | Familial partial lipodystrophy | PLIN1 knockout mice; adipocyte-specific knockout; overexpression |
| CIDEC | Partial lipodystrophy | CIDEC knockout mice; adipocyte differentiation models |
Lysosomal Acid Lipase Deficiency
Mutations in LIPA cause lysosomal acid lipase deficiency, which manifests as Wolman disease in infants and cholesteryl ester storage disease in older patients. These disorders are characterized by massive accumulation of cholesteryl esters and triglycerides in lysosomes, leading to hepatomegaly, liver failure, and premature atherosclerosis. Current therapies include enzyme replacement and hematopoietic stem cell transplantation, but CRISPR-based gene editing holds promise for correcting LIPA mutations.
Neutral Lipid Storage Disease
Neutral lipid storage disease with myopathy is caused by mutations in PNPLA2 (ATGL), leading to impaired lipolysis and accumulation of lipid droplets in muscle and other tissues. Patients present with muscle weakness, cardiomyopathy, and hepatomegaly. Similarly, mutations in ABHD5 cause Chanarin-Dorfman syndrome, characterized by ichthyosis and lipid storage in leukocytes. These conditions highlight the importance of lipolytic enzymes in maintaining lipid homeostasis.
Obesity and Metabolic Syndrome
Dysregulated lipid storage in adipose tissue contributes to obesity, insulin resistance, and type 2 diabetes. Excessive lipid accumulation in non-adipose tissues such as liver and muscle leads to lipotoxicity and organ dysfunction. Genetic variants in genes like PLIN1, CIDEC, and PPARG are associated with familial lipodystrophies and metabolic syndrome. Understanding these pathways is critical for developing targeted therapies.
Lipid Storage in Platelets and Transfusion Medicine
Platelets store lipids that affect their function and storage quality for transfusion. Changes in lipid composition during platelet storage can influence hemostatic efficacy and shelf life. Research into lipid storage mechanisms in platelets may improve transfusion outcomes.
From lipid storage-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate lipid storage in adipocytes? | CRISPR knockout in 3T3-L1 or human adipocytes; lipid droplet imaging |
| Does a disease-associated point mutation in LIPA affect enzyme activity? | Knock-in of the mutation in HEK293 or patient iPSCs; enzyme assay |
| Can overexpression of PLIN1 protect against lipotoxicity? | Overexpression in hepatocytes or cardiomyocytes; lipid quantification |
| What is the role of ATGL in muscle lipid storage? | Muscle-specific knockout mice; exercise challenge |
| How does a tagged lipid droplet protein localize during stress? | Knock-in of fluorescent tag (e.g., GFP) at endogenous locus; live imaging |
| Which genes are essential for lipid storage in yeast? | Genome-wide CRISPR library screening in S. pombe; lipid droplet staining |
How to Study the lipid storage Process
| Method | What It Measures | Typical Application |
|---|---|---|
| BODIPY 493/503 staining | Lipid droplet number and size | High-content imaging of cells under different conditions |
| Lipidomics (LC-MS) | Lipid species composition and abundance | Quantifying triglyceride and cholesteryl ester levels |
| CRISPR knockout screen | Genes affecting lipid storage | Identifying novel regulators in cell lines |
| Glycerol release assay | Lipolysis rate | Assessing ATGL/HSL activity in adipocytes |
| LIPA enzyme activity assay | Lysosomal acid lipase activity | Diagnosing LIPA deficiency and testing mutations |
| Live-cell imaging | Dynamics of lipid droplets | Tracking droplet growth and fusion |
| Western blot | Protein expression of lipid droplet proteins | Validating knockout or overexpression |
| qPCR | mRNA levels of lipogenic genes | Assessing transcriptional regulation |
Lipid Droplet Imaging
Fluorescence microscopy with dyes such as BODIPY 493/503 or Nile Red allows visualization and quantification of lipid droplets in cells and tissues. Live-cell imaging of fluorescently tagged lipid droplet proteins (e.g., PLIN2-GFP) enables dynamic studies of droplet formation and turnover. High-content imaging can be combined with CRISPR screens to identify regulators of lipid storage.
Lipidomics and Mass Spectrometry
Mass spectrometry-based lipidomics quantifies the abundance and composition of lipid species, including triglycerides, cholesteryl esters, and phospholipids. This approach can reveal changes in lipid storage under genetic or pharmacological perturbations. It is often used in conjunction with stable isotope labeling to measure lipid flux.
CRISPR Screening
Genome-wide CRISPR knockout or activation screens coupled with lipid droplet staining or lipid-sensitive reporters can identify novel genes that regulate lipid storage. These screens have uncovered roles for genes in lipid droplet biogenesis, lipolysis, and lipid signaling. Follow-up validation typically involves individual gene knockouts and lipid quantification.
Biochemical Assays for Lipolysis
Lipolysis can be measured by quantifying glycerol or free fatty acid release from cells or tissues. Enzyme activity assays for ATGL, HSL, and LIPA are used to assess their function in vitro. These assays are critical for characterizing mutations identified in patients with lipid storage diseases.
How CRISPR Can Be Used to Study GO:0019915 lipid storage
Knockout
CRISPR knockout of genes such as PLIN1, DGAT1, or ATGL in cell lines or animal models allows researchers to determine their necessity for lipid storage. For example, ATGL knockout mice accumulate lipid droplets in multiple tissues, confirming its role in lipolysis. Knockout studies in yeast have identified conserved genes required for lipid droplet formation.
Point Mutation
Introducing disease-associated point mutations (e.g., in LIPA or PNPLA2) via CRISPR knock-in enables functional studies of mutant proteins in isogenic backgrounds. These models help dissect the molecular consequences of specific mutations and test targeted therapies.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) or epitope tags at endogenous loci allows visualization and purification of lipid droplet proteins without overexpression artifacts. This approach is valuable for studying protein localization and interactions in real time.
Overexpression
CRISPR activation (CRISPRa) or traditional overexpression of genes like PLIN1 or CIDEC can enhance lipid storage and protect against lipotoxicity. Overexpression models are useful for gain-of-function studies and for identifying downstream effects on lipid metabolism.
How EDITGENE Supports lipid storage Research
Researchers studying lipid storage-related genes often need to determine whether a candidate gene is causally involved in lipid droplet formation, lipolysis, or lipid signaling. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation and drug discovery.
Contact EDITGENE today to design your custom CRISPR model for lipid storage research.
Frequently Asked Questions About lipid storage
What is lipid storage (GO:0019915)?
Lipid storage is the biological process of accumulating and maintaining lipids in cells or tissues, often in lipid droplets, for energy reserves and membrane synthesis.
What genes are involved in lipid storage?
Key genes include PLIN1, DGAT1, ATGL, HSL, LIPA, and CIDEC, which regulate lipid droplet formation, lipolysis, and lipid turnover.
What diseases are associated with lipid storage defects?
Lysosomal acid lipase deficiency, neutral lipid storage disease, Chanarin-Dorfman syndrome, and obesity are linked to impaired lipid storage.
How is lipid storage regulated?
Lipid storage is regulated by signaling pathways such as mTOR and AMPK, transcription factors like SREBP1 and PPARG, and post-translational modifications of lipid droplet proteins.
What are lipid droplets?
Lipid droplets are organelles that store neutral lipids and are coated by proteins like perilipins; they are central to lipid storage.
How can CRISPR be used to study lipid storage?
CRISPR knockout, knock-in, and overexpression models allow precise manipulation of lipid storage genes to study their function and disease relevance.
What model organisms are used to study lipid storage?
Yeast, reptiles, mice, and cell lines are commonly used to investigate conserved and specialized lipid storage mechanisms.
What methods measure lipid storage?
Methods include fluorescence microscopy with BODIPY, lipidomics, glycerol release assays, and CRISPR screens.
What is the role of LIPA in lipid storage?
LIPA encodes lysosomal acid lipase, which hydrolyzes cholesteryl esters and triglycerides in lysosomes; its deficiency causes lipid storage disease.
How does lipid storage affect platelet storage?
Lipid composition changes during platelet storage can affect platelet function and transfusion efficacy.
Conclusion
Lipid storage (GO:0019915) is a vital biological process that maintains energy homeostasis and cellular function. Its dysregulation underlies numerous metabolic and lysosomal storage diseases, making it a key area of biomedical research. Advances in CRISPR-based models and lipidomics are accelerating the discovery of novel regulators and therapeutic targets. EDITGENE provides essential tools to dissect these pathways with precision.
References
- 2. Green SM et al.. 2020. The Lipid Composition of Platelets and the Impact of Storage: An Overview.. Transfus Med Rev 34(2):108-116 PMID: 31987597
- 3. Jarc E et al.. 2019. Lipid Droplets and the Management of Cellular Stress.. Yale J Biol Med 92(3):435-452 PMID: 31543707
- 4. Price ER. 2017. The physiology of lipid storage and use in reptiles.. Biol Rev Camb Philos Soc 92(3):1406-1426 PMID: 27348513
- 5. Hapala I et al.. 2020. Metabolism of Storage Lipids and the Role of Lipid Droplets in the Yeast Schizosaccharomyces pombe.. Lipids 55(5):513-535 PMID: 32930427
- 6. Korbelius M et al.. 2023. Recent insights into lysosomal acid lipase deficiency.. Trends Mol Med 29(6):425-438 PMID: 37028992
- 7. Yu J et al.. 2017. The size matters: regulation of lipid storage by lipid droplet dynamics.. Sci China Life Sci 60(1):46-56 PMID: 27981432
- 8. Hänichen T et al.. 1997. Lipid storage disease.. Lab Anim Sci 47(3):275-9 PMID: 9241629
